Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing second quarter financial results, the Company will post them on the Coherus website at

Conference Call Information

When: Thursday, August 5, 2021 starting at 5:00 p.m. ET

Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)

Conference ID: 9146617


Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit

CONTACT: Contact Information:
Investor Contact:
McDavid Stilwell, CFO
Coherus BioSciences, Inc.

error: Content is protected !!